VANTA BIOSCIENCE LIMITED
Corporate Identification Number: U74999TG2016PLC109280
Our Company was originally incorporated as a private limited company under the
Companies Act 2013 pursuant to a certificate of incorporation issued by the Registrar of
Companies, Hyderabad dated April 29, 2016 with the name 'Vanta Biosciencs Private
Limited'. Our Company was converted into a public limited company pursuant to approval of
the shareholders at an extraordinary general meeting held on february 13, 2017 and
consequently, the name of our Company was changed to 'Vanta Bioscience Limited' and a
fresh certificate of incorporation consequent upon conversion in public Smiled company was
issued by the Registrar of Companies, Hyderabad on March) 17,2017.for further details of
our Company, see 'General Information' and 'History and Certain Other
Corporate Matters' on pages 41 and 86. respectively.
Registered Office: No 02/G/308/G, NO.3/FF/SF/1-20-248
Umajay Complex, Rasoolpura, Secunderabad, Hyderabad - 500 003, Telangana, India.
Tel.: +91 40 6657 5454 | Fax: +91 40 2790 8708 | E-mail:
info@vantabio.com | Website: www.vantabio.com
Contact Person; Zoheb Sayani. Company Secretary and Compliance Officer | Tel:
+91 40 6657 5454.
PROMOTERS OF THE COMPANY: MOHAN KRISHNA MULAKALA. DOPESH RAJA
MULAKALA,
0R.VYASMURTI MADHAVRAO SHINGATGERI DR. SOUMYA SIMHADRI, SHRAVAN CHINTAPATLA,
KARISHMA MULAKALA, SAJAN KIRAN MULAKALA. PRADEEP CHOWDARY AND OR. CHANDRASEKHAR RAO
SIMHADRI
BASIS OF ALLOTMENT
PUBLIC ISSUE OF 15.12.000 EQUITY SHARES OF FACE VALUE OF RS 10.00 EACH OF VANTA
BIOSCIENCE LIMITED ('OUR COMPANY' OR 'THE ISSUER') FOR CASH AT A PRICE
OF RS 50.00 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 40.00 PEP EQUITY SHARE)
('ISSUE PRICE') AGGREGATING TO RS 756.00 LAKHS ('THE ISSUE'). OF THE
ISSUE, 78.000 EQUITY SHARES AGGREGATING TO RS 39.00 LAKHS WILL BE RESERVED FOR
SUBSCRIPTION BY MARKET MAKER ('MARKET MAKER RESERVATION PORTION') THE ISSUE LESS
THE MARKET MAKER RESERVATION PORTION I. E. ISSUE OF 14,34,000 EQUITY SHARES OF FACE VALUE
OF RS 10.00 EACH AT AN ISSUE PRICE OF RS 50.00 PER EQUITY SHARE AGGREGATING TO RS 717.00
LAKHS IS HEREINAFTER REFERRED TO AS THE 'NET ISSUE'. THE ISSUE AND THE NET ISSUE
WILL CONSTITUTE 26.40% AND 25.03%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE
CAPITAL OF OUR COMPANY.
THIS BEING A FIXED PRICE, AS PER SUB CLAUSE (4) OF REGULATION 43 OF THE SEBI (ICDR)
REGULATIONS, 2009 AS AMENDED (THE ' SEBI REGULATIONS'). OUT OF THE NET ISSUE OF
14,34,000 EQUITY SHARES, NOT LESS THAN 50% SHALL BE AVALABLE TO RETAIL INDIVIDUAL
INVESTORS AND THE REMAINING TO INDIVIDUAL APPLICANTS OTHER THAN RETAIL INVESTORS AND OTHER
INVETORS INCLUDING CORPORATE BODIES OR INSTITUTIONS IRRESPECTIVE OF THE NUMBER OF SHARES
APPLIED FOR. IF THE RETAIL INDIVIDUAL INVESTOR CATEGORY IS ENTITLED TO MORE THAN 50% ON
PROPORATIONATE BASIS, THEY SHALL BE ALLOTTED THAT HIGHER PERCENTAGE.
THE FACE VALUE OF THE EQUITY SHARES IS RS 10 EACH AND
THE ISSUE PRICE OF RS 50 IS 5 TIMES OF THE FACE VALUE
ISSUE OPENED ON SEPTEMBER 25, 2017 AND CLOSED ON SEPTEMBER 27 2017
PROPOSED LISTING: FRIDAY, OCTOBER 6, 2017*
The Equity Shares offered through this Prospectus are proposed to be listed on the
BSE SME Platform. In terms of the Chapter XB of the SEBI (ICDR) Regulations. 2009. as
amended from time to time, we are not required to obtain an in-principal listing approval
for the shares being Offered in this Issue. However, our Company has received an approval
letter dated August 24, 2017 from BSE for using its name in this Prospectus for listing of
our Equity Shares on the SME Patform of BSE For the purpose of this Issue, BSE Limited
shall be the Designated Stock Exchange. The trading is proposed to be commenced with
effect from FRIDAY, OCTOBER 6.2017*.
*Subject to receipt of listing and trading approvals from the BSE.
All Applicants (except for underwriters for the underwriting portion) participated in the
Issue through APPLICATIONS SUPPORTED BY BLOCKED AMOUNT ('ASBA')
process by providing the details of their respective bank accounts in which the
corresponding application amounts were blocked by Sell Certified Syndicate Banks (the
'SCSBs').
SUBSCRIPTION DETAILS
The Issue has received 345 applications for 16386000 Equity Shares resulting in 1.12
times subscription (including reserved portion of Markal Maker). Due to technical
rejections the issue was undersubscribed Since this Issue was fully underwritten, and
requisite notice was sent to Underwriter i.e. Inventure Growth & Securities Limited
hence Underwriter has arranged for subscription for the shortfall of Equity Shares and
accordingly Issue was fully subscribed. The details of the applications received in the
Issue (before technical rejections and after returns due to unblocked amount) are as
follows:
Detail of the Applications Received (Before Technical Rejection):
Category |
No. of Applications |
% |
No. of Equity Shares |
% |
Subscription |
Non Retail Investor's |
99 |
28.61% |
873000 |
40.81% |
1.22 |
Retail Individual Investor's |
245 |
70.81% |
735000 |
34.36% |
1.03 |
Market Maker |
1 |
0.29% |
78000 |
3.65% |
1.00 |
Underwriter |
1 |
0.29% |
453000 |
21.18% |
1.00 |
TOTAL |
345 |
100.00% |
2139000 |
100.00% |
1.41 |
The details of applications rejected by the Registrar on technical grounds /
withdrawal are detailed below: Technical rejection,/ Withdrawal
Category |
No. of Applications |
Na. of Equity Shares |
Market Maker |
Nil |
Nil |
Non Retail Investors |
79 |
519000 |
Retail Individual Investors |
36 |
108000 |
TOTAL |
115 |
627000 |
After eliminating Technically Rejected applications, the following table gives
the details of Category wise net valid applications; Alter technical rejections
Category |
No.of
Applications |
% |
No.of Equity
Shares (Valid) |
% |
Subscription |
Proportionate No.of Equriy Shares
(Allocated) After Rounding Off) |
Market Maker |
1 |
0.43% |
78000 |
5.16% |
1.00 |
78000 |
Non Retail Investors |
20 |
8.66% |
354000 |
23.41% |
1.00 |
354000 |
Retail Individual Investors |
209 |
90.48% |
627000 |
41.47% |
1.00 |
627000 |
Underwriter Devolvement |
1 |
0.43% |
453000 |
29.96% |
1.00 |
453000 |
TOTAL |
231 |
100.00% |
512000 |
100.00 |
1.00 |
1512000 |
Since the issue is fully underwritten the shortfall of 453000 equity shares aggregating
to Rs 22650000.00 was arranged by the Underwriter in terms of the Underwriting agreement
dated August 24.2017.
Allocation: The Basis of Allotment was finalized In consultation with the
Designated Stock Exchange - BSE on October4,2017.
A. Allocation to Market Maker (After Technical Rejections): The Basis of
Allotment to the Market Maker at the issue price of Rs 50 per Equity Share, was finalized
in consultation with BSE. The category was subscribed by 1 .00 times. The total number of
shares allotted in this category is 78,000 Equity Shares.
B. Allocation to Retail Individual Investors (After Technical Rejections):
The Basis of Allotment to the Retail Individual Investors, at the Issue price of Rs 50 per
Equity Share, was finalized in consultation with BSE. The category was subscribed 0.874
times. Due to under subscription all the 209 valid applicants In this category have been
given full and firm allotment of 4,000 equity shares each and the under subscribed
portion, of 90,000 equity shares from Retail Individual Investors Category have been
spilled over to Underwriter Category. The total number of shares allotted in this category
is 627000 Equity Shares to 209 successful applicants.
C. Allocation to Non Retail Investors (After Technical Rejections): The
Basis of Allotment to the Non Retail Investors, at the issue price of Rs 50 per Equity
Share, was finalized in consultation with BSE. The category was subscribed 0.494 times.
The under subscribed 363000 Equity shares from Non Retail Investors Category have been
spilled over to Underwriters Category), The total number of shares allotted in this
category is 3,54,000 Equity Shares,
The Category-wise details of the Basis of Allotment are as under:
No. of Shanes
Applied for (Category wise) |
No. of
Applications Receives |
% to Total
|
Total No. of
Shares
Applied in
each Category |
% of
Total |
Proporti nate
Shares
Available |
Allocation per
Applicant
(Before
Rounding Off) |
Allocation
per
Applicant
(After
Rounding Off) |
Ratio of
Allottees to Applicants |
Total No.of
Shares allocated/
allolled |
Surplus/ Defecit |
6000 |
10 |
50.00 |
60000 |
16.95 |
121525 |
6000 |
6000 |
1:1 |
60000 |
-61525 |
9000 |
5 |
25.00 |
45000 |
12,71 |
91144 |
9000 |
9000 |
1:1 |
45000 |
-46144 |
12000 |
1 |
5,00 |
12000 |
3.39 |
24305 |
12000 |
12000 |
1:1 |
12000 |
-12305 |
21000 |
1 |
5.00 |
21000 |
5.93 |
42534 |
21000 |
21000 |
1:1 |
21000 |
-21534 |
39000 |
1 |
5.00 |
39000 |
11.02 |
78992 |
39000 |
39000 |
1:1 |
39000 |
-39992 |
78000 |
1 |
5.00 |
78000 |
22.03 |
157983 |
78000 |
78000 |
1:1 |
78000 |
-79983 |
99000 |
1 |
5.00 |
99000 |
27.97 |
200517 |
99000 |
99000 |
1:1 |
99000 |
-101517 |
TOTAL |
20 |
100.00 |
354000 |
100,00 |
717000 |
|
|
|
354000 |
-3,63,000 |
D. Allocation to Underwriters (After Technical Rejections): The
subscription for the shortfall of 453000 Equity Shares has been arranged by Underwriter at
the issue price of Rs 50 per Equity Shares. The under subscribed 90000 & 363000 shares
respectively from both Retail category & Non Retail category have been allotted to
Underwriter category. The Basis of Allotment for Underwriter Category at the issue price
of Rs 50 per Equity Share, was finalized in consultation with BSE. The total number of
shares allotted in this category is 4,53,000 Equity Shares to one Applicant.
The Board of Directors of the Company at Its meeting held on October 5,2017 has taken on
record the basis of Allocation of Equity Shares approved by the Designated Stock Exchange
viz. BSE and has authorized the corporate action for the transfer of the Equity Shares to
various successful applicants.
The CAN and allotment advice and/or notices are being dispatched to the address of the
Applicants as registered with the depositories on October 5,2017. Further, the
instructions to Self Certified Syndicate Banks are being processed on October 5, 2017. The
Equity Shares allocated to successful applicants are being credited to their beneficiary
accounts subject to validation of the account details with the depositories concerned. The
Company is taking steps to get the Equity Shares admitted for trading on the SME Platform
of BSE within six working days from the date of the closure of the Issue.
Note: All capitalized terms used and not defined herein shall have the
respective meaning assigned to them In the Prospectus dated September 1.2017
('Prospectus').
INVESTORS PLEASE NOTE
The details of the allotment mads would also be hosted on the website of the Registrar
to the issue, BIGSHARE SERVICES PRIVATE LIMITED at www.bigshareonline.com. All future
correspondence In this regard may kindly be addressed to the Registrar to the Issue
quoting full name of the First/ Sole applicants, serial number of the Application Form,
number of shares applied for and Rank Branch where the application had been lodged and
payment details at the address of the Registrar given below:
BIGSHARE SERVICES PRIVATE LIMITED
Bharat Tin Works Bldg. 1st Floor, opp. Vasant Oasis Makwana Road. Marol, (Andheri East),
Mumbai-4000059.
Tel: +91 22 62638200 | Fax: +91 22 62638299 E-mail:
ipo@bigshareonline.com
Website: www.bigshareonline.com
| Contact Person: Mr Babu Raphel | SEBI Registration No,:
INR000001385
Place: Hyderabad
Date : October 05. 2017 |
For Vanta Bioscience Limited
On behalf of the Board of Directors
Sd/-
Managing Director |
|